Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly
By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and…
‘Obesity medications may not make you thin or happy but they will improve your health’ – The Irish Times
They’re often billed – irresponsibly, say doctors – as weight-loss “wonder-drugs” or “miracle” jabs. But amid hype about…
Fat-loss drug Mounjaro now India’s No. 2 pharma brand | India News
NEW DELHI: Soaring demand for weight-loss therapies has brought Eli Lilly’s Mounjaro within striking distance of Indian pharma…
Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say
By Nancy Lapid (Reuters) -Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs should be the first medicines doctors…
Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say
By Nancy Lapid (Reuters) -Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs should be the first medicines doctors…
1 Reason Novo Nordisk (NVO) Is 1 of the Best Healthcare Stocks You Can Buy Today
Novo Nordisk is leading the race to get an oral weight loss GLP-1 drug approved. It needs to…
Wall Street rises to its first gain in 4 days
NEW YORK (AP) — U.S. stocks climbed Friday and trimmed their losses for the week after a report…
How the ‘Ozempic effect’ is reshaping the global economy
Michael Siluk/Alamy The new wave of weight-loss drugs has taken the world by storm. From Novo Nordisk’s Ozempic…
2 Undervalued Healthcare Stocks to Buy in 2025 and Hold for Decades
The overall stock market keeps reaching new heights, but some of its components are having a lousy year.…
Wegovy And Zepbound Cost Effective But They Could Break Drug Budgets
The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative…
Weight-loss drugs becoming better value for money, says watchdog
Popular GLP-1 weight-loss injections are now delivering greater value, according to a new report by a leading pharmaceutical…
Is LLY Underperforming the Healthcare Sector?
With a market cap of $694.9 billion, Eli Lilly and Company (LLY) is a leading global pharmaceutical company headquartered…